Intellectual Property & Science is now known as Clarivate Analytics
...and is no longer part of Thomson Reuters. You can still explore their products on this page.
The Incidence & Prevalence Database Overview
The most efficient way to look at the world’s epidemiology data
The Incidence and Prevalence Database (IPD) is the most efficient way to look at the world’s epidemiology data. The IPD covers over 4,500 diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates, cost and much more.
Our analysts track and report the epidemiological content for more than 280 medical journals and over 35 government and industry agencies. The global reach of the IPD includes all countries and regions where data is available.
IPD combines extensive epidemiological and market research experience with the breadth of Life Sciences service offerings from Thomson Reuters, creating a powerful combination for clients.
Combines the same premier information used by the world's leading pharmaceutical companies from products such as Thomson Reuters Pharma and Thomson Reuters Partnering (formerly IDDB). Features daily updates and pipeline information.
Accelerate a wide variety of strategic clinical development decisions by leveraging clinical trials information skillfully integrated with other scientific and competitive intelligence from Thomson Reuters.
Thomson Reuters Integrity℠ provides researchers with reliable, detailed information, from the perspective of a scientist, across multiple disciplines to support successful drug research and development.